Autolus Therapeutics (AUTL)
(Delayed Data from NSDQ)
$4.45 USD
+0.20 (4.71%)
Updated Jul 15, 2024 04:00 PM ET
After-Market: $4.46 +0.01 (0.22%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 8/1/24 |
---|---|
Current Quarter | -0.19 |
EPS Last Quarter | -0.24 |
Last EPS Surprise | -140.00% |
ABR | 1.38 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.78 |
Next Year | -0.62 |
EPS (TTM) | -1.20 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 0.40M | 22.71M | 73.58M |
# of Estimates | NA | 1 | 4 | 4 |
High Estimate | NA | 0.40M | 57.23M | 109.50M |
Low Estimate | NA | 0.40M | 10.23M | 47.86M |
Year ago Sales | 0.00M | 0.41M | 1.70M | 22.71M |
Year over Year Growth Est. | NA | -2.44% | 1,237.40% | 224.01% |
Earnings Estimates
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.19 | -0.20 | -0.78 | -0.62 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.23 | -0.25 | -0.98 | -0.82 |
High Estimate | -0.13 | -0.14 | -0.50 | -0.33 |
Low Estimate | -0.23 | -0.25 | -0.98 | -0.82 |
Year ago EPS | -0.26 | -0.26 | -1.20 | -0.78 |
Year over Year Growth Est. | 26.92% | 23.08% | 35.00% | 20.47% |
Agreement - Estimate Revisions
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 3 | 3 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.19 | -0.20 | -0.78 | -0.62 |
7 Days Ago | -0.19 | -0.20 | -0.78 | -0.62 |
30 Days Ago | -0.19 | -0.20 | -0.78 | -0.62 |
60 Days Ago | -0.21 | -0.23 | -0.71 | -0.57 |
90 Days Ago | -0.21 | -0.23 | -0.71 | -0.57 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (6/2024) |
Next Qtr (9/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.19 | -0.20 | -0.78 | -0.62 |
Zacks Consensus Estimate | -0.19 | -0.20 | -0.78 | -0.62 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.24 | -0.44 | -0.26 | -0.26 | NA |
Estimate | -0.10 | -0.26 | -0.24 | -0.22 | NA |
Difference | -0.14 | -0.18 | -0.02 | -0.04 | -0.10 |
Surprise | -140.00% | -69.23% | -8.33% | -18.18% | -58.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more